(30) revealed that exosome-derived lncRNA ELNAT1 promotes lymphangiogenesis and lymph node metastasis in bladder cancer through SUMOylation-dependent pathways, underscoring the potential of targeting exosomal lncRNAs for therapeutic intervention in aggressive bladder cancer subtypes. The gene discussed is SNHG16; the disease is urinary bladder carcinoma.